Laman UtamaIONS • BMV
add
Ionis Pharmaceuticals Inc
Tutup sebelumnya
$647.00
Julat tahun
$619.00 - $900.00
Permodalan pasaran
6.84B USD
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Mac 2025info | Perubahan T/T |
|---|---|---|
Hasil | 131.61J | 10.14% |
Perbelanjaan pengendalian | 83.55J | 39.85% |
Pendapatan bersih | -146.94J | -2.90% |
Margin untung bersih | -111.64 | 6.58% |
Pendapatan bagi setiap syer | -0.92 | -20.52% |
EBITDA | -144.05J | 1.56% |
Kadar cukai berkesan | -0.08% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 2.15B | -3.00% |
Jumlah aset | 2.81B | 1.77% |
Jumlah liabiliti | 2.34B | -5.28% |
Jumlah ekuiti | 475.73J | — |
Syer tertunggak | 159.16J | — |
Harga kepada buku | 216.39 | — |
Pulangan pada aset | -12.62% | — |
Pulangan pada modal | -14.71% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -146.94J | -2.90% |
Tunai daripada operasi | -150.78J | -0.56% |
Tunai daripada pelaburan | 170.46J | 123.98% |
Tunai daripada pembiayaan | 2.20J | -90.67% |
Perubahan bersih dalam tunai | 22.12J | 143.90% |
Aliran tunai bebas | -107.97J | -16.56% |
Perihal
Ionis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics. The company has three commercially approved medicines: Spinraza, Tegsedi, and Waylivra, and has four drugs in pivotal studies: tominersen for Huntington's disease, tofersen for SOD1-ALS, AKCEA-APO-LRx for cardiovascular disease, and AKCEA-TTR-LRx for all forms of TTR amyloidosis.
The company was named Isis Pharmaceuticals until December 2015. Wikipedia
Diasaskan
1989
Ibu pejabat
Tapak web
Pekerja
1,069
